tiprankstipranks
United Therapeutics Shareholders Show Strong Support at Annual Meeting
Company Announcements

United Therapeutics Shareholders Show Strong Support at Annual Meeting

Stay Ahead of the Market:

United Therapeutics (UTHR) has provided an announcement.

At the 2024 Annual Meeting of Shareholders, all director nominees were elected with a clear majority, with Jan Malcolm receiving the highest support. Shareholders also approved executive compensation, the restatement of the stock incentive plan, and the appointment of Ernst & Young as the public accounting firm. This demonstrates strong shareholder confidence in the company’s governance and strategic financial decisions.

See more data about UTHR stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles